Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Tags:
Consumer OTC Drugs

IoM RDA "CONCEPT PAPER" PROPOSES FOUR NUTRIENT INTAKE MEASUREMENTS

This article was originally published in The Tan Sheet

  • News
  • The Tan Sheet

Executive Summary

IoM RDA "CONCEPT PAPER" PROPOSES FOUR NUTRIENT INTAKE MEASUREMENTS based on deficiency, "average" dietary requirements, "recommended" dietary requirements and "upper safe" levels. In a "concept paper" called "How Should the Recommended Dietary Allowances be Revised" that was released May 6, the Institute of Medicine's Food & Nutrition Board suggested that the next edition of the Recommended Dietary Allowances should "review what is known about essential nutrients and important food components with respect to the four proposed reference points."

Table

View full table

Topics

Tags:
Consumer OTC Drugs
Latest Headlines

EU CHMP Opinions And MAA Updates

EU & South Korea Sign Deal On Exchange Of Confidential Information

Recent And Upcoming FDA Advisory Committee Meetings

Mismatch Between Growing Vaccine Pipeline and CDC’s ACIP Capacity

See All
UsernamePublicRestriction

Register

PS082752

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By